Skip to content
Search

Latest Stories

Practice pharmacist-led intervention to flag hazardous prescribing

A new partnership between the University of Nottingham and First Databank (FDB) will now help thousands of primary care prescribers to avoid hazardous prescribing.

The partnership will enable the university’s pharmacist-led information technology intervention (PINCER) interventions through FDB’s prescribing decision support tool OptimiseRx either at point of prescription or reauthorising of medications when PINCER safety indicators are relevant for specific patients.


This is part of the ongoing national roll-out of the PINCER prescribing safety indicators.

The PINCER intervention uses the principles of root cause analysis to identify patients at risk of hazardous prescribing.

A pharmacist then works with the practice to draw up action plans to address any immediate risk, and changes to system and process required to prevent any error from recurring.

Two-thirds of Clinical Commissioning Groups, who are already using the OptimiseRx technology medicine management system, will now alert GPs and other primary care prescribers, either at point of prescription or reauthorising of medications, when PINCER safety indicators are relevant for specific patients.

Kerry Oliver, managing director of PRIMIS, said: “The agreement to embed the PINCER indicators in OptimiseRx provides enormous reach for what will be of vital benefit to key prescribing decisions within thousands of practices throughout England.

“Including them in such a widely used medicines management system will be an important factor for the sustainability of the PINCER indicators, emphasising their role in evolving knowledge and processes that help to prevent medication errors from recurring.”

FDB is one of the first delivery partners to implement the PINCER Prescribing Safety Indicators through a software solution.

Darren Nichols, UK managing director at FDB, said: “We have listened to clinical commissioners and prescribers across the country who see the inclusion of the latest PINCER indicators within OptimiseRx as an important component of their adoption of national policies for helping to safeguard patients.

“Every day thousands of GP practices already draw on alerts within the technology to help them make the best prescribing decisions for patients, with primary care professionals prompted when best practice might indicate there could be better alternatives for patients. This important upgrade to the system with additional indicators will make those prompts even more comprehensive.”

More For You

Omega Pharmacy in Derbyshire Finds New Owner in Just 18 Days

Omega Pharmacy

Christie & Co

Omega Pharmacy in Derbyshire sold in just 18 days

Omega Pharmacy in Derbyshire has found a new owner in less than three weeks after being put on the market.

The pharmacy was previously owned by husband-and-wife duo Manny and Poonam Rai, who decided to sell it after a short period of ownership to focus on their other pharmacy in Coventry, according to Christie & Co.

Keep ReadingShow less
DHSC announces second list of March 2025 price concessions

A price concession only applies for the month it is granted.

Getty Images

March price concessions list released; prescription charge remains unchanged

The Department of Health and Social Care (DHSC) has released a second list of price concessions for March 2025, following ongoing discussions with Community Pharmacy England (CPE) regarding medicine pricing concerns raised by pharmacy owners.

A price concession is introduced when pharmacy contractors are unable to source a drug at or below the reimbursement price set out in the Drug Tariff.

Keep ReadingShow less
AstraZeneca partners with CEPI to develop multi-specific influenza antibody

AstraZeneca-CEPI collaboration aims to increase global access to antibody-based interventions

Getty Images

AstraZeneca secures £33M CEPI funding to develop multi-specific influenza antibody

AstraZeneca has joined forces with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance an innovative antibody technology that could help tackle future infectious disease outbreaks and pandemics swiftly and more affordably.

CEPI will provide up to US$43.5 million (£33.6 million) in funding to support the biopharmaceutical company in evaluating a type of antibody, known as a VHH (Variable Heavy domain of a Heavy chain -only antibody), through preclinical proof-of-concept studies and Phase 1 clinical trials.

Keep ReadingShow less
Community Pharmacy Patient Safety Group announces new vice-chair

Martin Sadr-Kazemi 's appointment follows the passing of Dr. José Moss in January 2025.

Martin Sadr-Kazemi appointed vice-chair of Community Pharmacy Patient Safety Group

The Community Pharmacy Patient Safety Group (CPPSG) has announced the appointment of Martin Sadr-Kazemi as its new vice-chair.

Martin, currently the medication safety officer and deputy superintendent pharmacist at Rowlands Pharmacy, has been an integral member of the CPPSG since its formation a decade ago, actively contributing to various initiatives.

Keep ReadingShow less
"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar

Pic credit: London Ambulance Service

"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar will create history when she becomes the first apprentice to become a qualified pharmacy technician through the London Ambulance Service.

Jaffar is just days away from completing her registration with the General Pharmaceutical Council.

Keep ReadingShow less